Trials / Completed
CompletedNCT06656039
A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma
Development and Validation of a Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma: a Multicenter Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (actual)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main goal of this observational study is to construct a predictive recurrence model for renal clear cell carcinoma through an artificial intelligence multimodal algorithm, which will improve the prognosis and survival time of ccRCC patients by helping clinicians to formulate individualised follow-up and to screen for appropriate adjuvant therapy candidates.
Conditions
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-10-10
- Completion
- 2024-10-10
- First posted
- 2024-10-24
- Last updated
- 2024-10-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06656039. Inclusion in this directory is not an endorsement.